BlackRock Fund Advisors’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

BlackRock Fund Advisors’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$56K	Buy	77 +3	+4%	+$2.44K	﹤0.01%	3749
2016 Q3	$71K	Hold	74	–	–	﹤0.01%	3689
2016 Q2	$106K	Buy	74 +68	+1,133%	+$87.5K	﹤0.01%	3659
2016 Q1	$7K	Buy	6 +1	+20%	+$1.15K	﹤0.01%	4034
2015 Q4	$6K	Buy	+5	New	+$6.52K	﹤0.01%	4106
2015 Q2	–	Sell	-71	Closed	-$211K	–	3907
2015 Q1	$211K	Sell	71 -5	-7%	-$16K	﹤0.01%	3469
2014 Q4	$250K	Buy	76 +6	+9%	+$21.2K	﹤0.01%	3421
2014 Q3	$248K	Sell	70 -5	-7%	-$19.4K	﹤0.01%	3402
2014 Q2	$289K	Sell	75 -600	-89%	-$2.26M	﹤0.01%	3356
2014 Q1	$2.74M	Buy	675 +21	+3%	+$93.8K	﹤0.01%	3088
2013 Q4	$2.43M	Sell	654 -329	-33%	-$1.25M	﹤0.01%	3113
2013 Q3	$3.87M	Buy	983 +125	+15%	+$938K	﹤0.01%	2963
2013 Q2	$8.46M	Buy	+858	New	+$9.5M	﹤0.01%	2352

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

BlackRock Fund Advisors's FRTX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) stake by 4.1% in Q4 2016, buying an estimated $2.44K and bringing the position to 77 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #3749.

BlackRock Fund Advisors first reported a position in FRTX in Q2 2013 and has held it in 13 quarters since. The position peaked at $8.46M in Q2 2013. 26 funds tracked by Wall St. Rank hold FRTX as of Q4 2016.

BlackRock Fund Advisors held 77 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $56K as of Q4 2016.
BlackRock Fund Advisors bought 3 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $2.44K.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3749 holding.
BlackRock Fund Advisors first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 13 quarters since.
BlackRock Fund Advisors's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $8.46M in Q2 2013.
26 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.